MassMutual Private Wealth & Trust’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio CTIC Stock Details CTIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-49	Closed	–	–	1803
2022 Q1	$0	Buy	+49	New	+$146	﹤0.01%	1699
2018 Q4	–	Sell	-20	Closed	-$43	–	1080
2018 Q3	$43	Hold	20	–	–	﹤0.01%	955
2018 Q2	$100	Hold	20	–	–	﹤0.01%	1097
2018 Q1	$78	Hold	20	–	–	﹤0.01%	969
2017 Q4	$54	Hold	20	–	–	﹤0.01%	895
2017 Q3	$64	Hold	20	–	–	﹤0.01%	1033
2017 Q2	$66	Hold	20	–	–	﹤0.01%	1002
2017 Q1	$84	Hold	20	–	–	﹤0.01%	987
2016 Q4	$82	Buy	+20	New	+$83	﹤0.01%	665
2016 Q2	$68	Hold	20	–	–	﹤0.01%	802
2016 Q1	$106	Hold	20	–	–	﹤0.01%	791
2015 Q4	$246	Hold	20	–	–	﹤0.01%	777
2015 Q3	$484	Sell	20 -22	-52%	-$380	﹤0.01%	796
2015 Q2	$1.19K	Buy	42 +22	+110%	+$425	﹤0.01%	665
2015 Q1	$362	Buy	+20	New	+$450	﹤0.01%	695
2014 Q4	–	Sell	-20	Closed	-$484	–	843
2014 Q3	$484	Buy	+20	New	+$520	﹤0.01%	758

Other funds holding CTIC

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return

LPC

Lion Point Capital New York $20.9M AUM 195.52% 1-Year Est. Return

MassMutual Private Wealth & Trust's CTIC Position: Q2 2022 in Review

MassMutual Private Wealth & Trust sold out of CTI BioPharma Corp. (DE) Common Stock (CTIC) in Q2 2022, closing a stake of 49 shares.

MassMutual Private Wealth & Trust first reported a position in CTIC in Q3 2014 and held it in 16 quarters. The position peaked at $1.19K in Q2 2015. 119 funds tracked by Wall St. Rank hold CTIC as of Q2 2022.

MassMutual Private Wealth & Trust reported no remaining CTI BioPharma Corp. (DE) Common Stock position as of Q2 2022 after selling out during the quarter.
MassMutual Private Wealth & Trust sold 49 CTI BioPharma Corp. (DE) Common Stock shares in Q2 2022.
MassMutual Private Wealth & Trust first reported a position in CTI BioPharma Corp. (DE) Common Stock in Q3 2014 and held it in 16 quarters.
MassMutual Private Wealth & Trust's CTI BioPharma Corp. (DE) Common Stock position peaked at $1.19K in Q2 2015.
119 funds tracked by Wall St. Rank held CTI BioPharma Corp. (DE) Common Stock as of Q2 2022.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2022, filed 7 Jul 2022.